182 related articles for article (PubMed ID: 15003465)
1. Expression of vascular endothelial growth factor receptor Flk-1 in canine mammary tumours.
Restucci B; Borzacchiello G; Maiolino P; Martano M; Paciello O; Papparella S
J Comp Pathol; 2004; 130(2-3):99-104. PubMed ID: 15003465
[TBL] [Abstract][Full Text] [Related]
2. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and their receptors (flt-1, flk-1, and flg-1) in canine vascular tumors.
Yonemaru K; Sakai H; Murakami M; Yanai T; Masegi T
Vet Pathol; 2006 Nov; 43(6):971-80. PubMed ID: 17099154
[TBL] [Abstract][Full Text] [Related]
3. The role of vascular endothelial growth factor and its receptor Flk-1/KDR in promoting tumour angiogenesis in feline and canine mammary carcinomas: a preliminary study of autocrine and paracrine loops.
Millanta F; Silvestri G; Vaselli C; Citi S; Pisani G; Lorenzi D; Poli A
Res Vet Sci; 2006 Dec; 81(3):350-7. PubMed ID: 16556453
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of vascular endothelial growth factor and vascular endothelial growth factor receptor in canine cutaneous fibrosarcomas.
Al-Dissi AN; Haines DM; Singh B; Kidney BA
J Comp Pathol; 2009 Nov; 141(4):229-36. PubMed ID: 19560781
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of vascular endothelial growth factor and vascular endothelial growth factor receptor associated with tumor cell proliferation in canine cutaneous squamous cell carcinomas and trichoepitheliomas.
Al-Dissi AN; Haines DM; Singh B; Kidney BA
Vet Pathol; 2007 Nov; 44(6):823-30. PubMed ID: 18039895
[TBL] [Abstract][Full Text] [Related]
6. Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease.
Kranenburg AR; de Boer WI; Alagappan VK; Sterk PJ; Sharma HS
Thorax; 2005 Feb; 60(2):106-13. PubMed ID: 15681497
[TBL] [Abstract][Full Text] [Related]
7. Expression of epidermal growth factor receptor and vascular endothelial growth factor in malignant canine epithelial nasal tumours.
Shiomitsu K; Johnson CL; Malarkey DE; Pruitt AF; Thrall DE
Vet Comp Oncol; 2009 Jun; 7(2):106-14. PubMed ID: 19453364
[TBL] [Abstract][Full Text] [Related]
8. Quantification of VEGF-C expression in canine mammary tumours.
Qiu C; Lin DD; Wang HH; Qiao CH; Wang J; Zhang T
Aust Vet J; 2008 Jul; 86(7):279-82. PubMed ID: 18616481
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of vascular endothelial growth factor in canine mammary tumours.
Santos AA; Oliveira JT; Lopes CC; Amorim IF; Vicente CM; Gärtner FR; Matos AJ
J Comp Pathol; 2010 Nov; 143(4):268-75. PubMed ID: 20570280
[TBL] [Abstract][Full Text] [Related]
10. Expression of vascular endothelial growth factor in canine inflammatory and non-inflammatory mammary carcinoma.
Millanta F; Caneschi V; Ressel L; Citi S; Poli A
J Comp Pathol; 2010 Jan; 142(1):36-42. PubMed ID: 19632688
[TBL] [Abstract][Full Text] [Related]
11. COX-2 over-expression correlates with VEGF and tumour angiogenesis in canine mammary cancer.
Queiroga FL; Pires I; Parente M; Gregório H; Lopes CS
Vet J; 2011 Jul; 189(1):77-82. PubMed ID: 20675158
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms.
Huh JI; Calvo A; Stafford J; Cheung M; Kumar R; Philp D; Kleinman HK; Green JE
Oncogene; 2005 Jan; 24(5):790-800. PubMed ID: 15592523
[TBL] [Abstract][Full Text] [Related]
13. Autocrine vascular endothelial growth factor signalling in breast cancer. Evidence from cell lines and primary breast cancer cultures in vitro.
Weigand M; Hantel P; Kreienberg R; Waltenberger J
Angiogenesis; 2005; 8(3):197-204. PubMed ID: 16328160
[TBL] [Abstract][Full Text] [Related]
14. Expression of vascular endothelial growth factor receptors is closely related to the histological grade of hepatocellular carcinoma.
Amaoka N; Saio M; Nonaka K; Imai H; Tomita H; Sakashita F; Takahashi T; Sugiyama Y; Takami T; Adachi Y
Oncol Rep; 2006 Jul; 16(1):3-10. PubMed ID: 16786116
[TBL] [Abstract][Full Text] [Related]
15. An autocrine loop directed by the vascular endothelial growth factor promotes invasiveness of human melanoma cells.
Lacal PM; Ruffini F; Pagani E; D'Atri S
Int J Oncol; 2005 Dec; 27(6):1625-32. PubMed ID: 16273219
[TBL] [Abstract][Full Text] [Related]
16. Different role of COX-2 and angiogenesis in canine inflammatory and non-inflammatory mammary cancer.
Clemente M; Sánchez-Archidona AR; Sardón D; Díez L; Martín-Ruiz A; Caceres S; Sassi F; Dolores Pérez-Alenza M; Illera JC; Dunner S; Peña L
Vet J; 2013 Aug; 197(2):427-32. PubMed ID: 23489848
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the vascular endothelial growth factor (VEGF) receptor Flk-1/KDR by estradiol through VEGF in uterus.
Hervé MA; Meduri G; Petit FG; Domet TS; Lazennec G; Mourah S; Perrot-Applanat M
J Endocrinol; 2006 Jan; 188(1):91-9. PubMed ID: 16394178
[TBL] [Abstract][Full Text] [Related]
18. Expression of vascular endothelial growth factor and receptor flk-1 in colon cancer liver metastases.
Cheng J; Slavin RE; Gallagher JA; Zhu G; Biehl TR; Swanstrom LL; Hansen PD
J Hepatobiliary Pancreat Surg; 2004; 11(3):164-70. PubMed ID: 15235888
[TBL] [Abstract][Full Text] [Related]
19. Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease.
Kaushal V; Mukunyadzi P; Dennis RA; Siegel ER; Johnson DE; Kohli M
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):584-93. PubMed ID: 15701844
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor, its receptor Flk-1, and hypoxia inducible factor-1alpha are involved in malignant transformation in dysplastic nodules of the liver.
Nakamura K; Zen Y; Sato Y; Kozaka K; Matsui O; Harada K; Nakanuma Y
Hum Pathol; 2007 Oct; 38(10):1532-46. PubMed ID: 17640715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
